229 related articles for article (PubMed ID: 12031965)
21. Cibinetide Protects Isolated Human Islets in a Stressful Environment and Improves Engraftment in the Perspective of Intra Portal Islet Transplantation.
Yao M; Domogatskaya A; Ågren N; Watanabe M; Tokodai K; Brines M; Cerami A; Ericzon BG; Kumagai-Braesch M; Lundgren T
Cell Transplant; 2021; 30():9636897211039739. PubMed ID: 34498509
[TBL] [Abstract][Full Text] [Related]
22. Profibrinolytic activity of the direct thrombin inhibitor melagatran and unfractionated heparin in platelet-poor and platelet-rich clots.
Semeraro F; Piro D; Rossiello MR; Ammollo T; Colucci M
Thromb Haemost; 2007 Dec; 98(6):1208-14. PubMed ID: 18064315
[TBL] [Abstract][Full Text] [Related]
23. A combination of a thrombin inhibitor and dexamethasone prevents the development of experimental disseminated intravascular coagulation in rats.
Elg M; Gustafsson D
Thromb Res; 2006; 117(4):429-37. PubMed ID: 15869787
[TBL] [Abstract][Full Text] [Related]
24. Mechanism of action of the oral direct thrombin inhibitor ximelagatran.
Mattsson C; Sarich TC; Carlsson SC
Semin Vasc Med; 2005 Aug; 5(3):235-44. PubMed ID: 16123910
[TBL] [Abstract][Full Text] [Related]
25. Direct thrombin inhibitor prevents delayed graft function in a porcine model of renal transplantation.
Giraud S; Thuillier R; Belliard A; Hebrard W; Nadeau C; Milin S; Goujon JM; Manguy E; Mauco G; Hauet T; Macchi L
Transplantation; 2009 Jun; 87(11):1636-44. PubMed ID: 19502954
[TBL] [Abstract][Full Text] [Related]
26. Effects of melagatran, a novel direct thrombin inhibitor, during experimental septic shock.
Eriksson M; Basu S; Larsson A; Mattsson C; Eriksson O; Kiiski R; Nordgren A
Expert Opin Investig Drugs; 2000 May; 9(5):1129-37. PubMed ID: 11060733
[TBL] [Abstract][Full Text] [Related]
27. Inhibition of instant blood-mediated inflammatory responses by co-immobilization of sCR1 and heparin on islets.
Luan NM; Iwata H
Biomaterials; 2013 Jul; 34(21):5019-24. PubMed ID: 23578554
[TBL] [Abstract][Full Text] [Related]
28. Low molecular weight dextran sulfate: a strong candidate drug to block IBMIR in clinical islet transplantation.
Johansson H; Goto M; Dufrane D; Siegbahn A; Elgue G; Gianello P; Korsgren O; Nilsson B
Am J Transplant; 2006 Feb; 6(2):305-12. PubMed ID: 16426314
[TBL] [Abstract][Full Text] [Related]
29. Composite islet-endothelial cell grafts: a novel approach to counteract innate immunity in islet transplantation.
Johansson U; Elgue G; Nilsson B; Korsgren O
Am J Transplant; 2005 Nov; 5(11):2632-9. PubMed ID: 16212622
[TBL] [Abstract][Full Text] [Related]
30. Ximelagatran/Melagatran: a review of its use in the prevention of venous thromboembolism in orthopaedic surgery.
Evans HC; Perry CM; Faulds D
Drugs; 2004; 64(6):649-78. PubMed ID: 15018597
[TBL] [Abstract][Full Text] [Related]
31. Dual islet transplantation modeling of the instant blood-mediated inflammatory reaction.
Martin BM; Samy KP; Lowe MC; Thompson PW; Cano J; Farris AB; Song M; Dove CR; Leopardi FV; Strobert EA; Jenkins JB; Collins BH; Larsen CP; Kirk AD
Am J Transplant; 2015 May; 15(5):1241-52. PubMed ID: 25702898
[TBL] [Abstract][Full Text] [Related]
32. Ximelagatran, an oral direct thrombin inhibitor, has a low potential for cytochrome P450-mediated drug-drug interactions.
Bredberg E; Andersson TB; Frison L; Thuresson A; Johansson S; Eriksson-Lepkowska M; Larsson M; Eriksson UG
Clin Pharmacokinet; 2003; 42(8):765-77. PubMed ID: 12846597
[TBL] [Abstract][Full Text] [Related]
33. Low molecular weight dextran sulfate prevents the instant blood-mediated inflammatory reaction induced by adult porcine islets.
Goto M; Johansson H; Maeda A; Elgue G; Korsgren O; Nilsson B
Transplantation; 2004 Mar; 77(5):741-7. PubMed ID: 15021838
[TBL] [Abstract][Full Text] [Related]
34. Additive effects of anticoagulants: recombinant human activated protein C and heparin or melagatran, in tissue factor-activated umbilical-cord plasma.
Koestenberger M; Gallistl S; Muntean W; Leschnik B; Fritsch P; Cvirn G
Thromb Haemost; 2005 Jul; 94(1):69-74. PubMed ID: 16113786
[TBL] [Abstract][Full Text] [Related]
35. Pharmacokinetics and pharmacodynamics of melagatran, a novel synthetic LMW thrombin inhibitor, in patients with acute DVT.
Eriksson H; Eriksson UG; Frison L; Hansson PO; Held P; Holmström M; Hägg A; Jonsson T; Lapidus L; Leijd B; Stockelberg D; Säfwenberg U; Taghavi A; Thorsén M
Thromb Haemost; 1999 Mar; 81(3):358-63. PubMed ID: 10102460
[TBL] [Abstract][Full Text] [Related]
36. Alleviation of instant blood-mediated inflammatory reaction in autologous conditions through treatment of human islets with NF-κB inhibitors.
Kanak MA; Takita M; Itoh T; SoRelle JA; Murali S; Kunnathodi F; Shahbazov R; Lawrence MC; Levy MF; Naziruddin B
Transplantation; 2014 Sep; 98(5):578-84. PubMed ID: 24798306
[TBL] [Abstract][Full Text] [Related]
37. Endothelial colony-forming cell coating of pig islets prevents xenogeneic instant blood-mediated inflammatory reaction.
Kim JH; Oh BJ; Lee HN; Park HS; Park SG; Park KS
Cell Transplant; 2011; 20(11-12):1805-15. PubMed ID: 21396165
[TBL] [Abstract][Full Text] [Related]
38. Effects of different routes of heparin on instant blood-mediated inflammatory reaction after portal vein islet transplantation.
Zhang S; Yan H; Ma X; Zheng W; Wang W
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2022 Jan; 47(1):1-7. PubMed ID: 35545357
[TBL] [Abstract][Full Text] [Related]
39. Differences in the clinically effective molar concentrations of four direct thrombin inhibitors explain their variable prothrombin time prolongation.
Warkentin TE; Greinacher A; Craven S; Dewar L; Sheppard JA; Ofosu FA
Thromb Haemost; 2005 Nov; 94(5):958-64. PubMed ID: 16363236
[TBL] [Abstract][Full Text] [Related]
40. No influence of obesity on the pharmacokinetics and pharmacodynamics of melagatran, the active form of the oral direct thrombin inhibitor ximelagatran.
Sarich TC; Teng R; Peters GR; Wollbratt M; Homolka R; Svensson M; Eriksson UG
Clin Pharmacokinet; 2003; 42(5):485-92. PubMed ID: 12739986
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
